Sanofi Consumer Healthcare Share Price | Sanofi Consumer Healthcare Stock Screener
SANOFICONR
Pharmaceuticals
Share Price NSE
₹4533.80
▼
-17.60 (-0.39%)
Share Price BSE
₹4558.25
▲
22.75 (0.50%)
As of August 6, 2026, the Sanofi Consumer Healthcare share price (NSE: SANOFICONR) is ₹4,533.80 on NSE and ₹4,558.25 on BSE, down 0.39% from the previous close, with shares trading between ₹4,521.00 and ₹4,555.90, and a 52-week range of ₹3,999.50–₹5,310.00.
Analyse SANOFICONR share price history and track historical price performance.
Use the Sanofi Consumer Healthcare stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Sanofi Consumer Healthcare Market Cap
₹10,431.03 Cr.
SANOFICONR P/E Ratio (TTM)
39.28
Sanofi Consumer Healthcare P/B Ratio
30.03
EPS (TTM)
₹104.27
Dividend Yield
1.65%
Debt to Equity
0.07
SANOFICONR 52 Week High
₹5310.00
Sanofi Consumer Healthcare 52 Week Low
₹3999.50
Operating Margin
37.00%
Profit Margin
27.45%
SANOFICONR Revenue (TTM)
₹969.00
EBITDA
₹372.00
Net Income
₹266.00
Total Assets
₹547.00
Total Equity
₹384.00
Sanofi Consumer Healthcare Share Price Chart
Screen Sanofi Consumer Healthcare share price with an interactive chart. Analyse SANOFICONR price trends and volatility across different timeframes.
Sanofi Consumer Healthcare Company Profile - Fundamental Screener
Screen Sanofi Consumer Healthcare company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for SANOFICONR shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE0UOS01011
Sanofi Consumer Healthcare Balance Sheet Screener
Screen SANOFICONR balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 |
|---|---|---|---|
| Assets | |||
| Total Assets | 547 | 431 | 345 |
| Current Assets | 494 | 392 | 335 |
| Fixed Assets | 36 | 29 | 5 |
| Liabilities | |||
| Total Liabilities | 0 | 0 | 0 |
| Current Liabilities | 35 | 28 | 8 |
| Non-Current Liabilities | 0 | 0 | 0 |
| Shareholders' Equity | |||
| Total Equity | 384 | 273 | 208 |
| Share Capital | 23 | 23 | 2 |
| Reserves & Surplus | 361 | 250 | 183 |
Sanofi Consumer Healthcare Income Statement Screener - Profit & Revenue Analysis
Screen Sanofi Consumer Healthcare income statement and profit fundamentals.
Analyze SANOFICONR quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Sanofi Consumer Healthcare share price evaluation.
| Item | None-None | 2025-March | 2024-March | 2023-March |
|---|---|---|---|---|
| Revenue | 969 | 897 | 738 | 560 |
| Expenses | 597 | 569 | 454 | 337 |
| EBITDA | 372 | 327 | 284 | 223 |
| Operating Profit % | 37.00% | 35.00% | 37.00% | 39.00% |
| Depreciation | 13 | 12 | 5 | 2 |
| Interest | 2 | 2 | 4 | 0 |
| Profit Before Tax | 357 | 320 | 247 | 219 |
| Tax | 94 | 80 | 66 | 54 |
| Net Profit | 266 | 240 | 181 | 165 |
| EPS | 115.50 | 104.27 | 78.59 | 71.60 |
Sanofi Consumer Healthcare Cash Flow Screener - Liquidity Fundamentals
Screen SANOFICONR cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March |
|---|---|---|---|
| Operating Activities | 175 | 439 | 0 |
| Investing Activities | 8 | 2 | 0 |
| Financing Activities | -135 | -116 | 2 |
| Net Cash Flow | 48 | 325 | 2 |
Sanofi Consumer Healthcare Shareholding Pattern Screener
See Sanofi Consumer Healthcare shareholding pattern with promoter, FII, and DII holdings.
Check Sanofi Consumer Healthcare promoter holding and ownership changes for SANOFICONR on TickJournal.
| Item | 2026-Jun | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Oct |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 71.27% | 71.27% | 71.27% | 71.27% | 71.27% | 60.40% | 60.40% | 60.40% |
| FII Holding | 2.60% | 2.76% | 2.83% | 2.94% | 3.24% | 4.53% | 4.42% | 4.87% |
| DII Holding | 17.86% | 17.57% | 17.33% | 17.21% | 16.89% | 25.48% | 25.35% | 24.51% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 6.18% | 6.26% | 6.25% | 6.26% | 6.30% | 6.58% | 7.01% | 7.41% |
| Other Holding | 2.10% | 2.14% | 2.31% | 2.32% | 2.30% | 3.01% | 2.83% | 2.82% |
| Shareholder Count | 47,511 | 48,418 | 48,075 | 48,808 | 49,632 | 51,859 | 55,734 | 57,598 |
Sanofi Consumer Healthcare Share Dividend Screener - Share Yield Analysis
Check Sanofi Consumer Healthcare dividend history with payout and yield data.
View Sanofi Consumer Healthcare dividend details including ex-dates and amounts for SANOFICONR stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹75.00 | 1.74% |
| 2024-March | ₹55.00 | 1.14% |
| 2023-March | ₹0.00 | 0.00% |
| 2022-March | ₹0.00 | 0.00% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
Sanofi Consumer Healthcare Stock Index Membership
See which indices include Sanofi Consumer Healthcare stock.
Check SANOFICONR index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
BSE INDEX BSE HC
BSE INDEX SMLCAP
NIFTY MICROCAP250
NIFTY TOTAL MKT
Sanofi Consumer Healthcare Market Events Screener - Corporate Actions
Get Sanofi Consumer Healthcare corporate actions including splits, bonuses, and buybacks.
Check Sanofi Consumer Healthcare stock events that may affect SANOFICONR share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-07-28 | 2026-07-28 | Quarterly Result Announcement | NA | 2.52% |
| 2026-06-26 | 2026-06-26 | Annual General Meeting | NA | -0.22% |
| 2026-06-19 | 2026-06-19 | Dividend | ₹ 75.00 /share | 23.72% |
| 2026-04-28 | 2026-04-28 | Quarterly Result Announcement | NA | 1.47% |
| 2026-02-25 | 2026-02-25 | Quarterly Result Announcement | NA | -4.76% |
| 2025-11-12 | 2025-11-12 | Quarterly Result Announcement | NA | -5.60% |
| 2025-08-04 | 2025-08-04 | Quarterly Result Announcement | NA | -2.10% |
| 2025-05-05 | 2025-05-05 | Annual General Meeting | NA | 3.96% |
| 2025-05-02 | 2025-05-02 | Quarterly Result Announcement | NA | 0.05% |
| 2025-04-17 | 2025-04-17 | Dividend | ₹ 55.00 /share | 5.07% |
| 2025-02-20 | 2025-02-20 | Quarterly Result Announcement | NA | 0.62% |
| 2024-11-12 | 2024-11-12 | Quarterly Result Announcement | NA | 0.97% |
Sanofi Consumer Healthcare Competitors Screener - Peer Comparison
Screen SANOFICONR competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 471,229 | 38.61 | 61,674 | 12.69% | 11,565 | 57.78 |
| Divis Laboratories | 222,410 | 75.54 | 11,067 | 13.95% | 2,568 | 77.88 |
| Torrent Pharmaceuticals | 191,325 | 88.55 | 13,886 | 20.34% | 2,138 | 58.22 |
| Cipla | 117,945 | 35.36 | 29,045 | 2.24% | 3,870 | 56.84 |
| Zydus Life Science | 113,704 | 21.73 | 27,658 | 17.64% | 5,026 | 54.04 |
| Lupin | 110,193 | 20.29 | 29,039 | 26.75% | 5,356 | 49.10 |
| Mankind Pharma | 100,688 | 49.43 | 14,636 | 14.85% | 1,938 | 42.29 |
| Laurus Labs | 99,873 | 89.74 | 6,868 | 22.01% | 890 | 82.61 |
| Dr Reddys Laboratories | 97,873 | 30.67 | 35,059 | 3.90% | 4,158 | 38.37 |
| Aurobindo Pharma | 91,249 | 26.38 | 33,385 | 3.21% | 3,376 | 57.25 |
Sanofi Consumer Healthcare Company Announcements - News Screener
Screen SANOFICONR latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-08-02 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-07-31 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-07-31 | Results - Financial Results For June 30 2026 | - |
| 2026-07-31 | Board Meeting Outcome for Outcome Of Board Meeting Held On Tuesday 28Th July 2026 | - |
| 2026-07-22 | Board Meeting Intimation for Board Meeting Intimation For Consideration And Approval Of Unaudited Financial Results For The Quarter And Half Year Ended 30Th June 2026. | - |
| 2026-07-09 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-06-29 | Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s | - |
| 2026-06-29 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | - |
| 2026-06-26 | Shareholder Meeting / Postal Ballot-Outcome of AGM | - |
| 2026-06-26 | Closure of Trading Window | - |
| 2026-06-05 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-06-04 | Shareholder Meeting - AGM On 26Th June 2026 | - |
| 2026-06-04 | Shareholder Meeting - AGM On 26Th June 2026 | - |
| 2026-06-04 | Reg. 34 (1) Annual Report. | - |
| 2026-06-02 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-05-27 | Intimation Of Record Date For Payment Of Final Dividend For FY 2025 | - |
| 2026-05-27 | Intimation Of Book Closure For Payment Of Final Dividend For Fy 2025 | - |
| 2026-05-27 | Intimation Of 3Rd Annual General Meeting Of The Company | - |
| 2026-05-25 | Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s | - |
| 2026-05-25 | Board Meeting Outcome for Intimation Of Appointment Of Statutory Auditor Pursuant To Regulation 30 Of SEBI (LODR) Regulations 2015 | - |